These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16869997

  • 1. Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects.
    Ouguerram K, Maugeais C, Gardette J, Magot T, Krempf M.
    Br J Nutr; 2006 Jul; 96(1):100-6. PubMed ID: 16869997
    [Abstract] [Full Text] [Related]

  • 2. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J, Hurt-Camejo E.
    Lipids Health Dis; 2017 Aug 10; 16(1):149. PubMed ID: 28797250
    [Abstract] [Full Text] [Related]

  • 3. Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
    Ferchaud-Roucher V, Zair Y, Aguesse A, Krempf M, Ouguerram K.
    J Clin Endocrinol Metab; 2020 Oct 01; 105(10):. PubMed ID: 32805740
    [Abstract] [Full Text] [Related]

  • 4. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
    Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.
    J Pharmacol Exp Ther; 2003 Jul 01; 306(1):332-7. PubMed ID: 12684543
    [Abstract] [Full Text] [Related]

  • 5. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2006 Jun 01; 26(6):1350-6. PubMed ID: 16574893
    [Abstract] [Full Text] [Related]

  • 6. Effects of fish oil supplementation on apolipoprotein B100 production and lipoprotein metabolism in normolipidaemic males.
    Bordin P, Bodamer OA, Venkatesan S, Gray RM, Bannister PA, Halliday D.
    Eur J Clin Nutr; 1998 Feb 01; 52(2):104-9. PubMed ID: 9505154
    [Abstract] [Full Text] [Related]

  • 7. Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans.
    Kasim-Karakas SE, Herrmann R, Almario R.
    Metabolism; 1995 Sep 01; 44(9):1223-30. PubMed ID: 7666799
    [Abstract] [Full Text] [Related]

  • 8. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug 01; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

  • 9. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ, Bastida S, Viejo JM, Terpstra AH.
    Eur J Nutr; 1999 Feb 01; 38(1):20-7. PubMed ID: 10338684
    [Abstract] [Full Text] [Related]

  • 10. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
    Meyer BJ, Hammervold T, Rustan AC, Howe PR.
    Lipids; 2007 Mar 01; 42(2):109-15. PubMed ID: 17393216
    [Abstract] [Full Text] [Related]

  • 11. Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL.
    Gill JM, Brown JC, Caslake MJ, Wright DM, Cooney J, Bedford D, Hughes DA, Stanley JC, Packard CJ.
    Am J Clin Nutr; 2003 Jul 01; 78(1):47-56. PubMed ID: 12816770
    [Abstract] [Full Text] [Related]

  • 12. N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.
    Connor WE, DeFrancesco CA, Connor SL.
    Ann N Y Acad Sci; 1993 Jun 14; 683():16-34. PubMed ID: 8352438
    [Abstract] [Full Text] [Related]

  • 13. n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes.
    Tremblay AJ, Lamarche B, Hogue JC, Couture P.
    J Diabetes Res; 2016 Jun 14; 2016():2909210. PubMed ID: 27034958
    [Abstract] [Full Text] [Related]

  • 14. Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1-Related Lipodystrophy.
    Vergès B, Vantyghem MC, Reznik Y, Duvillard L, Rouland A, Capel E, Vigouroux C.
    Arterioscler Thromb Vasc Biol; 2024 Aug 14; 44(8):1873-1883. PubMed ID: 38899472
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.
    Bailhache E, Briand F, Nguyen P, Krempf M, Magot T, Ouguerram K.
    Eur J Clin Invest; 2004 Aug 14; 34(8):527-34. PubMed ID: 15305886
    [Abstract] [Full Text] [Related]

  • 16. Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells.
    Lindsey S, Pronczuk A, Hayes KC.
    J Lipid Res; 1992 May 14; 33(5):647-58. PubMed ID: 1535648
    [Abstract] [Full Text] [Related]

  • 17. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.
    Egert S, Somoza V, Kannenberg F, Fobker M, Krome K, Erbersdobler HF, Wahrburg U.
    Eur J Clin Nutr; 2007 Mar 14; 61(3):314-25. PubMed ID: 16969378
    [Abstract] [Full Text] [Related]

  • 18. Suppression by diets rich in fish oil of very low density lipoprotein production in man.
    Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R.
    J Clin Invest; 1984 Jul 14; 74(1):82-9. PubMed ID: 6736254
    [Abstract] [Full Text] [Related]

  • 19. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.
    Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA.
    Diabetologia; 2007 Aug 14; 50(8):1593-602. PubMed ID: 17541540
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.